Tarsus Pharmaceuticals (TARS) Net Equity Issued and Repurchased (2020 - 2026)
Tarsus Pharmaceuticals (TARS) reported Net Equity Issued and Repurchased of $1.86 million for Q2 2026, compared with -$354,000 a year earlier and up 54.8% from the prior quarter.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Tarsus Pharmaceuticals' Net Equity Issued and Repurchased came in at -$125.42 million; for FY2025, it was $6.28 million, down 32.9% from FY2024.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of -41.5% (FY2020 to FY2025).
- By year, Net Equity Issued and Repurchased came in at $9.37 million in FY2024 (+850.8%), $985,000 in FY2023 (+113.2%), $462,000 in FY2022 (+109.0%) and $221,000 in FY2021 (-99.8%).
- The Q2 2026 figure ranks as the highest quarterly Net Equity Issued and Repurchased since Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Tarsus Pharmaceuticals | 3.40 Bn | 2.35 Bn | 161.80 Mn | 1.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.86 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | -128.49 Mn |
| Jun 30, 2025 | -354,000.00 |
| Mar 31, 2025 | 135.13 Mn |
| Dec 31, 2024 | -88.92 Mn |
| Sep 30, 2024 | -43,000.00 |
| Jun 30, 2024 | -274,000.00 |
| Mar 31, 2024 | 98.60 Mn |
| Dec 31, 2023 | -98.39 Mn |
| Sep 30, 2023 | 98.91 Mn |
| Jun 30, 2023 | 452,000.00 |
| Mar 31, 2023 | 13,000.00 |
| Dec 31, 2022 | -73.89 Mn |
| Sep 30, 2022 | -218,000.00 |
| Jun 30, 2022 | 74.57 Mn |
| Dec 31, 2021 | 221,000.00 |
| Jun 30, 2021 | -19,000.00 |
| Mar 31, 2021 | 19,000.00 |
| Dec 31, 2020 | 51.70 Mn |
API Access
Tarsus Pharmaceuticals Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();